Cargando…

The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease

Alzheimer’s Disease (AD) is the most common form of dementia, characterised by intra- and extracellular protein aggregation. In AD, the cellular protein quality control (PQC) system is derailed and fails to prevent the formation of these aggregates. Especially the mitochondrial paralogue of the cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekker, Françoise A., Rüdiger, Stefan G. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249562/
https://www.ncbi.nlm.nih.gov/pubmed/34222342
http://dx.doi.org/10.3389/fmolb.2021.697913
_version_ 1783716921824247808
author Dekker, Françoise A.
Rüdiger, Stefan G. D.
author_facet Dekker, Françoise A.
Rüdiger, Stefan G. D.
author_sort Dekker, Françoise A.
collection PubMed
description Alzheimer’s Disease (AD) is the most common form of dementia, characterised by intra- and extracellular protein aggregation. In AD, the cellular protein quality control (PQC) system is derailed and fails to prevent the formation of these aggregates. Especially the mitochondrial paralogue of the conserved Hsp90 chaperone class, tumour necrosis factor receptor-associated protein 1 (TRAP1), is strongly downregulated in AD, more than other major PQC factors. Here, we review molecular mechanism and cellular function of TRAP1 and subsequently discuss possible links to AD. TRAP1 is an interesting paradigm for the Hsp90 family, as it chaperones proteins with vital cellular function, despite not being regulated by any of the co-chaperones that drive its cytosolic paralogues. TRAP1 encloses late folding intermediates in a non-active state. Thereby, it is involved in the assembly of the electron transport chain, and it favours the switch from oxidative phosphorylation to glycolysis. Another key function is that it ensures mitochondrial integrity by regulating the mitochondrial pore opening through Cyclophilin D. While it is still unclear whether TRAP1 itself is a driver or a passenger in AD, it might be a guide to identify key factors initiating neurodegeneration.
format Online
Article
Text
id pubmed-8249562
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82495622021-07-03 The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease Dekker, Françoise A. Rüdiger, Stefan G. D. Front Mol Biosci Molecular Biosciences Alzheimer’s Disease (AD) is the most common form of dementia, characterised by intra- and extracellular protein aggregation. In AD, the cellular protein quality control (PQC) system is derailed and fails to prevent the formation of these aggregates. Especially the mitochondrial paralogue of the conserved Hsp90 chaperone class, tumour necrosis factor receptor-associated protein 1 (TRAP1), is strongly downregulated in AD, more than other major PQC factors. Here, we review molecular mechanism and cellular function of TRAP1 and subsequently discuss possible links to AD. TRAP1 is an interesting paradigm for the Hsp90 family, as it chaperones proteins with vital cellular function, despite not being regulated by any of the co-chaperones that drive its cytosolic paralogues. TRAP1 encloses late folding intermediates in a non-active state. Thereby, it is involved in the assembly of the electron transport chain, and it favours the switch from oxidative phosphorylation to glycolysis. Another key function is that it ensures mitochondrial integrity by regulating the mitochondrial pore opening through Cyclophilin D. While it is still unclear whether TRAP1 itself is a driver or a passenger in AD, it might be a guide to identify key factors initiating neurodegeneration. Frontiers Media S.A. 2021-06-18 /pmc/articles/PMC8249562/ /pubmed/34222342 http://dx.doi.org/10.3389/fmolb.2021.697913 Text en Copyright © 2021 Dekker and Rüdiger. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Dekker, Françoise A.
Rüdiger, Stefan G. D.
The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
title The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
title_full The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
title_fullStr The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
title_full_unstemmed The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
title_short The Mitochondrial Hsp90 TRAP1 and Alzheimer’s Disease
title_sort mitochondrial hsp90 trap1 and alzheimer’s disease
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249562/
https://www.ncbi.nlm.nih.gov/pubmed/34222342
http://dx.doi.org/10.3389/fmolb.2021.697913
work_keys_str_mv AT dekkerfrancoisea themitochondrialhsp90trap1andalzheimersdisease
AT rudigerstefangd themitochondrialhsp90trap1andalzheimersdisease
AT dekkerfrancoisea mitochondrialhsp90trap1andalzheimersdisease
AT rudigerstefangd mitochondrialhsp90trap1andalzheimersdisease